Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations
Increasingly, big pharma is viewing the outsourcing of pharmaceutical manufacturing as a strategic move that would enable them to focus on their core competencies such as R&D. At the same time, the patent expiry of key blockbuster drugs worth $45 billion and biologics worth $30 billion is expected to reduce the capacity utilisation rates of their manufacturing facilities,
Read more ...
GE Healthcare and M+W Group form strategic alliance in vaccines, insulin and biopharmaceuticals
GE Healthcare, the healthcare business of GE (NYSE: GE) and M+W Group, a leading global engineering, construction and project management company, have formed a strategic alliance aimed at overcoming the lack of key biopharmaceuticals, especially in emerging nations.
Read more ...
IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
IBM (NYSE: IBM) announced it is contributing a massive database of chemical data extracted from millions of patents and scientific literature to the National Institutes of Health. This contribution will allow researchers to more easily visualize important relationships among chemical compounds to aid in drug discovery and support advanced cancer research.
Read more ...
Springer Healthcare Announces Agreement With ASCO®
Springer Healthcare, part of Springer Science+Business Media, has signed an extensive three-year reprints and sales agreement effective 1 January 2012 with the American Society of Clinical Oncology® (ASCO), the world's leading professional organization representing physicians who care for people with cancer.
Read more ...
Unparalleled global progress in HIV response but sustained investment vital
Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term. The latest report by the World Health Organization (WHO), UNICEF and UNAIDS Report on the Global HIV/AIDS Response indicates that increased access to HIV services resulted in a 15% reduction of new infections over the past decade and a 22% decline in AIDS-related deaths in the last five years.
Read more ...
Bio-Images and Medimetrics Partner to Deliver the Next Generation of Smart Pill Technology
Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool.
Read more ...
Innovative technology improves care and reduces costs
The use of long-distance video and data hookups to link remote community hospitals with stroke neurologists in large centres provides the same level of care as having everyone in the same room, according to a new study presented today at the Canadian Stroke Congress.
Read more ...